We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Amgen Inc | NASDAQ:AMGN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.95 | -1.55% | 314.09 | 314.01 | 314.15 | 315.395 | 310.76 | 314.63 | 1,129,261 | 18:37:52 |
From May 2019 to May 2024
Amgen Inc. said its earnings increased in the third quarter, driven by strong growth of key drugs such as cancer therapy Kyprolis. "Amgen Posts Strong Results on Higher Sales--Update" published at 5:39 p.m. and an earlier version at 4:01 p.m. misspelled the name of drug as Krypolis in the lead of the story.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Amgen Chart |
1 Month Amgen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
